AMICATHIICATÉTERDEPERFUSIÓNPARA IAM
Mexico·Clase III·V. SURGICAL AND HEALING MATERIALS·MEDSTENT, S.A. DE C.V.·Registered April 10, 2021AMICATH®IIESUNCATÉTERDEDILATACIÓNY PERFUSIÓN CORONARIA PARA ELDIAGNÓSTICOYTRATAMIENTODELESIONESARTERIALES CON OCLUSIÓN TOTAL AGUDA.ESTÁPREVISTASUUTILIZACIÓNENSALASDEHEMODINÁMICA POR PARTE DE MÉDICOSHEMODINAMISTAS U OTRO PERSONALSANITARIO ESPECIALIZADO EMPLEANDOTÉCNICAS ESTÁNDARES U OTRO PERSONALSANITARIO ESPECIALIZADO EMPLEANDOTÉCNICAS ESTÁNDARES DE ICP/ACTP CONACCESO VÍA FEMORAL O VÍA BRAQUIAL
AMICATH®II IS A CORONARY DILATATION AND PERFUSION CATHETER FOR THE DIAGNOSIS AND TREATMENT OF ARTERIAL LESIONS WITH ACUTE TOTAL OCCLUSION. IT IS INTENDED FOR USE IN HAEMODYNAMICS ROOMS BY HAEMODYNAMIC DOCTORS OR OTHER SPECIALISED HEALTH PERSONNEL USING STANDARD TECHNIQUES OR OTHER SPECIALISED HEALTH PERSONNEL USING STANDARD PCI/PTCA TECHNIQUES WITH FEMORAL OR BRACHIAL ACCESS
- Risk Class / Clase de Riesgo
- Clase III
- Product Type (Spanish)
- V. MATERIALES QUIRÚRGICOS Y DE CURACIÓN
- Product Type (English)
- V. SURGICAL AND HEALING MATERIALS
- Trade Name (Spanish)
- CATÉRTER DE PERFUSIÓN
- Trade Name (English)
- INFUSION CATHETER
- Analysis ID
- 1552C2021 SSA
- Registration Date
- April 10, 2021
- Name (Spanish)
- MEDSTENT, S.A. DE C.V.
- Name (English)
- MEDSTENT, S.A. DE C.V.
Access comprehensive regulatory information for AMICATHIICATÉTERDEPERFUSIÓNPARA IAM (AMICATHIICATÉTERDEPERFUSIÓNPARA IAM) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 1552C2021 SSA and manufactured by MEDSTENT, S.A. DE C.V.. The device was registered on April 10, 2021.
This page provides complete registration details including product type (V. SURGICAL AND HEALING MATERIALS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.